285 related articles for article (PubMed ID: 33029570)
1. Molecular docking between human TMPRSS2 and SARS-CoV-2 spike protein: conformation and intermolecular interactions.
Hussain M; Jabeen N; Amanullah A; Baig AA; Aziz B; Shabbir S; Raza F; Uddin N
AIMS Microbiol; 2020; 6(3):350-360. PubMed ID: 33029570
[TBL] [Abstract][Full Text] [Related]
2. Molecular docking analysis reveals the functional inhibitory effect of Genistein and Quercetin on TMPRSS2: SARS-COV-2 cell entry facilitator spike protein.
Manjunathan R; Periyaswami V; Mitra K; Rosita AS; Pandya M; Selvaraj J; Ravi L; Devarajan N; Doble M
BMC Bioinformatics; 2022 May; 23(1):180. PubMed ID: 35578172
[TBL] [Abstract][Full Text] [Related]
3. Structural insights and inhibition mechanism of TMPRSS2 by experimentally known inhibitors Camostat mesylate, Nafamostat and Bromhexine hydrochloride to control SARS-coronavirus-2: A molecular modeling approach.
Sonawane KD; Barale SS; Dhanavade MJ; Waghmare SR; Nadaf NH; Kamble SA; Mohammed AA; Makandar AM; Fandilolu PM; Dound AS; Naik NM; More VB
Inform Med Unlocked; 2021; 24():100597. PubMed ID: 34075338
[TBL] [Abstract][Full Text] [Related]
4. Different residues in the SARS-CoV spike protein determine cleavage and activation by the host cell protease TMPRSS2.
Reinke LM; Spiegel M; Plegge T; Hartleib A; Nehlmeier I; Gierer S; Hoffmann M; Hofmann-Winkler H; Winkler M; Pöhlmann S
PLoS One; 2017; 12(6):e0179177. PubMed ID: 28636671
[TBL] [Abstract][Full Text] [Related]
5.
Salleh MZ; Deris ZZ
Life (Basel); 2022 Feb; 12(2):. PubMed ID: 35207518
[TBL] [Abstract][Full Text] [Related]
6. Structure of Human TMPRSS2 in Complex with SARS-CoV-2 Spike Glycoprotein and Implications for Potential Therapeutics.
Vankadari N; Ketavarapu V; Mitnala S; Vishnubotla R; Reddy DN; Ghosal D
J Phys Chem Lett; 2022 Jun; ():5324-5333. PubMed ID: 35675654
[TBL] [Abstract][Full Text] [Related]
7. Computational studies reveal Fluorine based quinolines to be potent inhibitors for proteins involved in SARS-CoV-2 assembly.
Sarkar N; Thakur A; Ghadge J; Rath SL
J Fluor Chem; 2021 Oct; 250():109865. PubMed ID: 34393265
[TBL] [Abstract][Full Text] [Related]
8. Prediction of the Effects of Variants and Differential Expression of Key Host Genes
Hossain MS; Tonmoy MIQ; Fariha A; Islam MS; Roy AS; Islam MN; Kar K; Alam MR; Rahaman MM
Bioinform Biol Insights; 2021; 15():11779322211054684. PubMed ID: 34720581
[TBL] [Abstract][Full Text] [Related]
9. Targeting androgen regulation of TMPRSS2 and ACE2 as a therapeutic strategy to combat COVID-19.
Deng Q; Rasool RU; Russell RM; Natesan R; Asangani IA
iScience; 2021 Mar; 24(3):102254. PubMed ID: 33681723
[TBL] [Abstract][Full Text] [Related]
10. Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System.
Costa LB; Perez LG; Palmeira VA; Macedo E Cordeiro T; Ribeiro VT; Lanza K; Simões E Silva AC
Front Cell Dev Biol; 2020; 8():559841. PubMed ID: 33042994
[TBL] [Abstract][Full Text] [Related]
11. Understanding the role of conserved proline and serine residues in the SARS-CoV-2 spike cleavage sites in the virus entry, fusion, and infectivity.
Khatri R; Lohiya B; Kaur G; Maithil V; Goswami A; Sarmadhikari D; Asthana S; Samal S
3 Biotech; 2023 Oct; 13(10):323. PubMed ID: 37663753
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 host cell entry: an in silico investigation of potential inhibitory roles of terpenoids.
Gyebi GA; Ogunyemi OM; Ibrahim IM; Ogunro OB; Adegunloye AP; Afolabi SO
J Genet Eng Biotechnol; 2021 Aug; 19(1):113. PubMed ID: 34351542
[TBL] [Abstract][Full Text] [Related]
13. Improving Soluble Expression of SARS-CoV-2 Spike Priming Protease TMPRSS2 with an Artificial Fusing Protein.
Ye X; Ling X; Wu M; Bai G; Yuan M; Rao L
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445653
[TBL] [Abstract][Full Text] [Related]
14. Exploring the phytochemicals of
Gurung AB; Ali MA; Lee J; Aljowaie RM; Almutairi SM
J King Saud Univ Sci; 2022 Aug; 34(6):102155. PubMed ID: 35702062
[No Abstract] [Full Text] [Related]
15. Quinolines-Based SARS-CoV-2 3CLpro and RdRp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: An
Alexpandi R; De Mesquita JF; Pandian SK; Ravi AV
Front Microbiol; 2020; 11():1796. PubMed ID: 32793181
[TBL] [Abstract][Full Text] [Related]
16. Virtual screening by targeting proteolytic sites of furin and TMPRSS2 to propose potential compounds obstructing the entry of SARS-CoV-2 virus into human host cells.
Vardhan S; Sahoo SK
J Tradit Complement Med; 2022 Jan; 12(1):6-15. PubMed ID: 33868970
[TBL] [Abstract][Full Text] [Related]
17. Herbal Compounds Dauricine and Isoliensinine Impede SARS-CoV-2 Viral Entry.
Dabrell SN; Li YC; Yamaguchi H; Chen HF; Hung MC
Biomedicines; 2023 Oct; 11(11):. PubMed ID: 38001915
[TBL] [Abstract][Full Text] [Related]
18. Prediction of deleterious non-synonymous SNPs of TMPRSS2 protein combined with Molecular Dynamics Simulations and free energy analysis to identify the potential peptide substrates against SARS-CoV-2.
Ramachandran B; Nadeem A; Mohanprasanth A; Saravanan M
J Biomol Struct Dyn; 2024 Apr; ():1-15. PubMed ID: 38592189
[TBL] [Abstract][Full Text] [Related]
19. Tannic acid suppresses SARS-CoV-2 as a dual inhibitor of the viral main protease and the cellular TMPRSS2 protease.
Wang SC; Chen Y; Wang YC; Wang WJ; Yang CS; Tsai CL; Hou MH; Chen HF; Shen YC; Hung MC
Am J Cancer Res; 2020; 10(12):4538-4546. PubMed ID: 33415017
[TBL] [Abstract][Full Text] [Related]
20. Ambroxol Hydrochloride Inhibits the Interaction between Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein's Receptor Binding Domain and Recombinant Human ACE2.
Olaleye OA; Kaur M; Onyenaka CC
bioRxiv; 2020 Sep; ():. PubMed ID: 32995775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
